Broadwood Partners, L.P. - 10%+ Owner at Oncocyte Corp

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
OCX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Broadwood Partners, L.P. - trading volume in the past year for Oncocyte Corp

Holdings reported by Broadwood Partners, L.P. for Oncocyte Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, no par value 11.4M $23.4M $2.05 Feb 6, 2025 Direct
Common Stock, no par value 11.4M $23.4M $2.05 Feb 6, 2025 Indirect
Warrant to Purchase Common Stock 150K Feb 6, 2025 Direct Common Stock 150K
Warrant to Purchase Common Stock 150K Feb 6, 2025 Indirect Common Stock 150K
Series A Convertible Preferred Stock 0 Apr 15, 2024 Direct Common Stock 3.84M
Series A Convertible Preferred Stock 0 Apr 15, 2024 Indirect Common Stock 3.84M

Transactions reported by Broadwood Partners, L.P. for Oncocyte Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.